FOLICK JEFFREY 4

4 · Bright Health Group Inc. · Filed Jun 30, 2021

Insider Transaction Report

Form 4

Period: 2021-01-03

Bright Health Group Inc.BHG

FOLICK JEFFREY

Director

Transactions

Exercise/Conversion
Common Stock
2021-04-03$0.63/sh+11,382$7,133→ 1,230,396 total
Conversion
Common Stock
2021-06-28+106,271→ 1,348,052 total
Conversion
Common Stock
2021-06-28+96,237→ 1,537,112 total
Exercise/Conversion
Stock Options (Right to Buy)
2021-01-03−11,385→ 170,754 total
Exercise: $0.63Exp: 2028-04-03→ Common Stock (11,385 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2021-04-03−11,382→ 136,605 total
Exercise: $0.63Exp: 2028-04-03→ Common Stock (11,382 underlying)
Conversion
Common Stock
2021-06-28+92,823→ 1,440,875 total
Exercise/Conversion
Common Stock
2021-03-03$0.63/sh+22,767$14,268→ 1,219,014 total
Exercise/Conversion
Common Stock
2021-05-03$0.63/sh+11,385$7,135→ 1,241,781 total
Conversion
Common Stock
2021-06-28+39,933→ 1,577,045 total
Exercise/Conversion
Stock Options (Right to Buy)
2021-03-03−22,767→ 147,987 total
Exercise: $0.63Exp: 2028-04-03→ Common Stock (22,767 underlying)
Conversion
Series A Preferred Stock
2021-06-28−156,570→ 0 total
→ Common Stock (106,271 underlying)
Exercise/Conversion
Common Stock
2021-01-03$0.63/sh+11,385$7,135→ 1,196,247 total
Exercise/Conversion
Stock Options (Right to Buy)
2021-05-03−11,385→ 125,220 total
Exercise: $0.63Exp: 2028-04-03→ Common Stock (11,385 underlying)
Conversion
Series B Preferred Stock
2021-06-28−30,941→ 0 total
→ Common Stock (92,823 underlying)
Conversion
Series C Preferred Stock
2021-06-28−32,079→ 0 total
→ Common Stock (96,237 underlying)
Conversion
Series D Preferred Stock
2021-06-28−13,311→ 0 total
→ Common Stock (39,933 underlying)

Footnotes (4)

[F1]Reflects 1-for-3 forward stock split effected on June 2, 2021.
[F2]These stock options vest over four years as follows: (a) 25% vested on April 3, 2019 (one year after the grant date), and (b) 1/48 of the original grant amount (of 546,411) vests in monthly installments for the following three years.
[F3]Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.
[F4]Each share of the Issuer's Preferred Stock Series, B, C and D converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.

Documents

1 file

4
form4-06302021_090602.xmlPrimary